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Figure 1. US scan shows echoic material (between calipers) at
the conﬂuence of the left and middle HVs, suggestive of
obstructing clot. (Available in color online at www.jvir.org.)
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Editor:
This report was granted exemption from institutional
review board approval. The authors report a case of
endovascular recanalization and stent placement in the
right hepatic vein (HV) by using a collateral loop-guided
approach through a caudate-lobe patent accessory HV.
A 9-year-old boy presented with a 2-month history of
abdominal distension, left thigh pain, and claudication.
Blood tests revealed erithrocytosis, γ-glutamyl transpep-
tidase level of 143 U/L, and lactate level of 2,30 mmol/L.
Coagulation, thrombophilia studies, and copper levels
were normal. Autoantibody screens were negative, and
autoimmune lymphoproliferative syndrome was exclu-
ded by ﬂow cytometry. Genetic analysis showed a
nonspeciﬁc JAK2 gene polymorphism.
Doppler ultrasound (US) demonstrated narrowed
HVs with decreased ﬂow (10 cm/s), and thrombosis of
the conﬂuence of the right, middle, and left HVs (Fig 1).
A tortuous caudate lobe vein was identiﬁed. The portal
vein had antegrade ﬂow with normal velocity (33 cm/s).
The hepatic artery had normal resistive indices.
Hepatomegaly (liver length at the midclavicular line of
15 cm) and ascites were noted. Computed tomographic
(CT) angiography conﬁrmed the HV obstruction and
demonstrated caudate lobe hypertrophy with retro-
hepatic vena cava compression (3 mm). The caudate-
lobe accessory HV draining into the inferior vena cava
(IVC) was identiﬁed (Fig 2).
The patient was referred to our institution for angio-
graphic evaluation and, if possible, retrograde recanali-
zation of the HVs. The venography and endovascular
treatment were performed through a right transjugular
approach. A 6-F, 11-cm-long sheath introducer (Boston
Scientiﬁc, Natick, Massachusetts) was inserted into the
right jugular vein, through which a 65-cm-long, 5-F
multipurpose 0.038-inch catheter (Cordis, Warren,None of the authors have identiﬁed a conﬂict of interest.
http://dx.doi.org/10.1016/j.jvir.2014.07.023New Jersey) was advanced into the abdominal IVC. It
was impossible to selectively cannulate the main HVs
because of the conﬂuence obstruction. The accessory HV
draining the caudate lobe directly into the IVC was
cannulated. A venous shunt between the accessory
caudate lobe vein and the right HV was found. A
roadmap image of this shunt was obtained (Fig 3).
A 180-cm-long, 0.035-inch nitinol guide wire (Terumo,
Tokyo, Japan) was advanced through the shunt into the
right HV. Venography at this time revealed a 4-cm
obstruction of the right HV. It was possible to cross the
obstructing clot and reach the IVC with the Terumo
guide wire. The 6-F introducer was replaced by an
11-cm-long, 8-F sheath introducer (Boston Scientiﬁc),
which allowed a loop fashioned from a 300-cm-long,
0.014-inch Cougar LS Nitinol guide wire (Meditronic,Figure 2. Postcontrast coronal CT image shows unenhacing
caudate-lobe HV communicating with the unopaciﬁed main HV
through an intrahepatic collateral vessel (arrows). Note the
presence of ascites (asterisk).
Baptista et al ’ JVIR136 ’ Letters to the EditorMinneapolis, Minnesota) to be pushed through the
jugular access. This was used to snare the Terumo wire
extremity within the IVC. The looped Cougar LS wire
was pulled through the jugular venous access, and the
ﬂoppy end of the Terumo wire was exteriorized (Fig 4a).
An Absolute Pro self-expanding vascular nitinol stent
(8.0 mm in diameter and 40 mm in length; Abbott,
Abbott Park, Illinois) on an 80-cm sheath was advanced
over the ﬂoppy end of the Terumo wire and deployed
within the right HV (Fig 4b). A Charger balloon (7.0 mm
in diameter and 40 mm in length; Boston Scientiﬁc) wasFigure 4. (a) Radiograph shows a Terumo guide wire loop (arrow)
(b) Digital subtraction image shows a stent (arrowheads) on the Terum
www.jvir.org.)
Figure 3. Venographic roadmap of the caudate lobe HV
(arrows) and collateral vessel between the caudate-lobe HV
and right HV (arrowheads).used to fully expand the stent, after which stent patency
was conﬁrmed. During the procedure, the patient
received low molecular weight heparin (3,000 IU), and,
the following day, long-term anticoagulation was com-
menced for 1 year.
US evaluation 4 days later revealed a decrease in
hepatic size (liver length at the midclavicular line of 14
cm). Doppler US showed turbulent hepatofugal ﬂow
within the stent (Fig 5), with velocities reaching 130 cm/s.
The portal vein maintained antegrade ﬂow and normal
velocity (50 cm/s) and the ascites had resolved.Figure 5. Doppler US image demonstrates stent (arrow)
patency within the right HV 4 days after treatment. (Available
in color online at www.jvir.org.)
from the IVC through the venous shunt and back into the IVC.
o guide wire ﬂoppy end arm (arrow). (Available in color online at
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did not show evidence of stent thrombosis, and there was
clinical improvement (increase in weight of 7 kg and
normal development, but a γ-glutamyl transpeptidase
level of 140 U/L).
Endovascular recanalization of the HVs used to be
done with balloon angioplasty, but it has been shown
that stent implantation decreases the restenosis rate to
7% regardless of the obstruction etiology (1); stent
placement is therefore now common practice.
Zhang et al (2), who studied the long-term effect of stent
placement in Budd–Chiari syndrome, obtained an overall
HV stent patency rate of 90.9%. The risk of stent occlusion
was higher in HV stents (9.1%) than in IVC stents (3.3%).
Antegrade percutaneous approaches have been
described, but present a potentially increased hemorrha-
gic risk as the liver capsule is punctured (2). Even though
it is probably safer, our approach cannot be widely used
because direct drainage of the caudate lobe into the IVC
is not always present. However, if this phenomenon is
noted, we believe venography of this vessel should be
performed to identify possible shunts. It is recognized
that the caudate-lobe HV is engorged in 50% of patients
with Budd–Chiari syndrome, and serves a pivotal role in
liver drainage through multiple collateral vessels (3).
In summary, this report presents a case of a successful
percutaneous endovascular recanalization, stent implan-
tation, and balloon-aided stent expansion in the right
HV in Budd–Chiari syndrome achieved through a
collateral approach in a patient with a shunt between a
patent caudate accessory HV and right HV.REFERENCES
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This report meets criteria for institutional review board
exemption at our institute. Transarterial chemoemboli-
zation is a common procedure for the management of
primary and secondary hepatic malignancies. The tradi-
tional preparation process of the chemoembolic suspen-
sion involves mixing the chemotherapeutic agents
(usually doxorubicin, mitomycin, or cisplatin or a
combination) with ethiodized oil (Lipiodol; Guerbet
LLC, Bloomington, Indiana) across a three-way open
transfer device (OTD) (1). However, the high viscosity of
the agents tends to degrade the material in the OTD
and the syringes and can lead to hazardous leakage
of the chemoembolic suspension onto the procedure
ﬁeld posing a risk to the operator and other staff in
the procedure area. The National Institute of
Occupational Safety and Health, the American Society
of Health-System Pharmacists, and the International
Society of Oncology Pharmacy Practitioners have
published alerts and guidelines regarding the safe hand-
ling of chemotherapeutic and other potentially vesicant
drugs (2).
A closed-system drug transfer system (CSDTS) that
would eliminate this risk to operators is desirable. Various
CSDTS exist, such as ChemoLock (ICU Medical, San
Clemente, California) and OnGuard (B. Braun Medical,
Inc, Bethlehem, Pennsylvania); however, their use in
interventional radiology procedures has not been
described to our knowledge. One CSDTS, the PhaSeal
system (Becton, Dickinson and Company, Dublin,
Ireland), is designed to ensure leak-free transfer of
hazardous material that meets National Institute of
Occupational Safety and Health guidelines, and its use
has been reported by pharmacies to prepare chemother-
apeutic and other hazardous vesicant agents (2). In our
practice, we often faced leakage of chemotherapeutic
agents while mixing with ethiodized oil or injecting the
suspension secondary to “melt-down” of the plastic OTD.
We reviewed our practice with the Pharmacy and Thera-
peutics committee at our hospital who recommended our
use of the PhaSeal system. This system had been used by
our hospital pharmacy for the past 4 years. Consequently,
we introduced the PhaSeal transfer system to replace the
three-way OTD.
We present our initial experience using this system as a
replacement for the three-way OTD. The device consists
of the PhaSeal Injector Luer Lock and Connector Luer
Lock components and a ﬂuid-dispensing connector
